Cetirizine Hcl Capsule
NDC Package 55910-784-15
Package Information
Cetirizine Hcl capsules is cetirizine is an antihistamine used to relieve allergy symptoms such as watery eyes, runny nose, itching eyes/nose, sneezing, hives, and itching. This formulation utilizes a capsule delivery system. Marketed by Dolgencorp Inc, this product is identified by NDC 55910-784 and is authorized under FDA application NDA022429.
Identification & Billing
- RxCUI: 1014675 - cetirizine HCl 10 MG 24HR Oral Capsule
- RxCUI: 1014675 - cetirizine hydrochloride 10 MG Oral Capsule
- RxCUI: 1014675 - cetirizine HCl 10 MG 24 HR Oral Capsule
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 55910 - Dolgencorp Inc
- 55910-784 - Cetirizine Hcl
- 55910-784-15 - 1 BOTTLE, PLASTIC in 1 CARTON / 40 CAPSULE in 1 BOTTLE, PLASTIC
- 55910-784 - Cetirizine Hcl
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (55910-784). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 55910-784-15 identifies a specific commercial package of 1 bottle, plastic in 1 carton / 40 capsule in 1 bottle, plastic of Cetirizine Hcl, a human over the counter drug labeled by Dolgencorp Inc. This capsule is formulated for oral use and contains cetirizine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Dolgencorp Inc on November 25, 2024. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
Cetirizine is an antihistamine used to relieve allergy symptoms such as watery eyes, runny nose, itching eyes/nose, sneezing, hives, and itching. It works by blocking a certain natural substance (histamine) that your body makes during an allergic reaction. Cetirizine does not prevent hives or prevent/treat a serious allergic reaction (such as anaphylaxis). Therefore, if your doctor has prescribed epinephrine to treat allergic reactions, always carry your epinephrine injector with you. Do not use cetirizine in place of your epinephrine.
How is this Dolgencorp Inc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 55910078415. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.